LaunchPoint Ventures, LLC – Trademark Portfolio
Entity Type: 16
LaunchPoint Ventures, LLC holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include DISCOVERY HEALTH PARTNERS. The owner is based in Itasca, IL.
Two Pierce Place, Suite 1900
Itasca, IL 60143
Showing of trademarks Trademarks
Trademark Classifications
LaunchPoint Ventures, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does LaunchPoint Ventures, LLC have?
LaunchPoint Ventures, LLC has 9 U.S. trademarks filed with the USPTO. Of these, 6 registered, 3 abandoned.
What trademark classes does LaunchPoint Ventures, LLC file in?
LaunchPoint Ventures, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.
What are LaunchPoint Ventures, LLC's most well-known trademarks?
LaunchPoint Ventures, LLC's registered trademark portfolio includes well-known marks such as DISCOVERY HEALTH PARTNERS. These are among 6 currently registered trademarks in the portfolio.
What is LaunchPoint Ventures, LLC's trademark registration success rate?
LaunchPoint Ventures, LLC has a 67% trademark registration rate, with 6 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.